Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Crooks

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
JCO Precision Oncology|July 22, 2024
Molecular Characterization of Metastatic Oncocytoma With Exceptional Response to Treatment: A Case ReportBradley R Webster, Christopher J Ricketts, Cathy D Vocke, et al.
Chembiochem : a European Journal of Chemical Biology|October 26, 2018
Photoinducible Oncometabolite DetectionRhushikesh A Kulkarni, Chloe A Briney, Daniel R Crooks, et al.
Urologic Oncology|February 26, 2025
Characterization of metabolic and imaging profiles in the diagnosis of succinate dehydrogenase- related hereditary pheochromocytomas and paragangliomasJessica Y Hsueh, Neil Mendhiratta, Julie Solomon, et al.
Blood|May 18, 2010
Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathwayLyora A Cohen, Lucia Gutierrez, Avital Weiss, et al.
Cell Death & Disease|April 25, 2025
Targeting metabolic vulnerability by combining NAMPT inhibitors and disulfiram for treatment of recurrent ovarian cancerKei Kudo, Yoshimi Endo Greer, Daniel R Crooks, et al.
Metabolites|July 25, 2025
Understanding the Metabolic Effects of Surgically Induced Renal Ischemia in Humans: A Temporal ApproachBhargav Arimilli, Tyler A On, Vaishnavi S Srirama, et al.
Neoplasia (New York, N.Y.)|October 8, 2025
Metabolic and imaging phenotypes associated with RB1 and TP53 loss in prostate cancerFahim Ahmad, Margaret White, Kazutoshi Yamamoto, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
Metabolic and imaging phenotypes associated with <i>RB1</i> and <i>TP53</i> loss in prostate cancerFahim Ahmad, Margaret White, Kazutoshi Yamamoto, et al.
Journal of the National Cancer Institute|January 1, 2016
SDHB-Deficient Cancers: The Role of Mutations That Impair Iron Sulfur Cluster DeliveryNeetu Saxena, Nunziata Maio, Daniel R Crooks, et al.
Frontiers in Oncology|January 30, 2023
Targeting mutant p53-R248W reactivates WT p53 function and alters the onco-metabolic profileKate Brown, Lisa M Miller Jenkins, Daniel R Crooks, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
JCO Precision Oncology|July 22, 2024
Molecular Characterization of Metastatic Oncocytoma With Exceptional Response to Treatment: A Case ReportBradley R Webster, Christopher J Ricketts, Cathy D Vocke, et al.
Chembiochem : a European Journal of Chemical Biology|October 26, 2018
Photoinducible Oncometabolite DetectionRhushikesh A Kulkarni, Chloe A Briney, Daniel R Crooks, et al.
Urologic Oncology|February 26, 2025
Characterization of metabolic and imaging profiles in the diagnosis of succinate dehydrogenase- related hereditary pheochromocytomas and paragangliomasJessica Y Hsueh, Neil Mendhiratta, Julie Solomon, et al.
Blood|May 18, 2010
Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathwayLyora A Cohen, Lucia Gutierrez, Avital Weiss, et al.
Cell Death & Disease|April 25, 2025
Targeting metabolic vulnerability by combining NAMPT inhibitors and disulfiram for treatment of recurrent ovarian cancerKei Kudo, Yoshimi Endo Greer, Daniel R Crooks, et al.
Metabolites|July 25, 2025
Understanding the Metabolic Effects of Surgically Induced Renal Ischemia in Humans: A Temporal ApproachBhargav Arimilli, Tyler A On, Vaishnavi S Srirama, et al.
Neoplasia (New York, N.Y.)|October 8, 2025
Metabolic and imaging phenotypes associated with RB1 and TP53 loss in prostate cancerFahim Ahmad, Margaret White, Kazutoshi Yamamoto, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
Metabolic and imaging phenotypes associated with <i>RB1</i> and <i>TP53</i> loss in prostate cancerFahim Ahmad, Margaret White, Kazutoshi Yamamoto, et al.
Journal of the National Cancer Institute|January 1, 2016
SDHB-Deficient Cancers: The Role of Mutations That Impair Iron Sulfur Cluster DeliveryNeetu Saxena, Nunziata Maio, Daniel R Crooks, et al.
Frontiers in Oncology|January 30, 2023
Targeting mutant p53-R248W reactivates WT p53 function and alters the onco-metabolic profileKate Brown, Lisa M Miller Jenkins, Daniel R Crooks, et al.
Pageof 6